Results for tag: "Blastomycosis Drug"

The Blastomycosis Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat blastomycosis, a fungal infection caused by the fungus Blastomyces dermatitidis. These drugs are typically antifungal medications, such as itraconazole, amphotericin B, and fluconazole. Treatment of blastomycosis is often long-term and requires close monitoring by a physician. The Blastomycosis Drug market is highly competitive, with many companies offering products for the treatment of this infection. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Other companies, such as Cipla, Lupin, and Sun Pharmaceuticals, also offer products for the treatment of blastomycosis. Show Less Read more